《《《《《《《《内容已删除》》》》》》》》》

PLX4032

PLX4032

PLX4032

PLX4032

1

Initial trials of PLX4032 suggest it may be as good as, or even better than, ipilimumab at improving sufferers' survival .

PLX4023 的初期试验结果证实这种药物在增加患者存活率方面可能和 ipilimumab 一样好，甚至优于 ipilimumab 。

2

The most promising is PLX4032, a molecule which blocks the action of the protein produced by a specific mutation of a gene called B-RAF.

最有可能结合的药物是 PLX4032 ，这种分子可阻断由 B-RAF 等位基因突变后产生的蛋白质的活动。

3

PLX4032 does not target the NRAS mutation, so the cancer can begin to regrow.

由于 PLX4032 对 NRAS 没有作用，所以癌症就可以重新开始生长。

热词推荐

大家在看